KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 14,110
-30 (-0.21%)
At close: Sep 17, 2025
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 156.18 billion as of September 19, 2025. Its market cap has decreased by -21.75% in one year.
Market Cap
156.18B
Enterprise Value
163.43B
Revenue
85.34B
Ranking
n/a
PE Ratio
107.92
Stock Price
14,110.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 156.18B, a decrease of -15.01%. That is a compound annual growth rate of -3.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 156.18B | -6.47% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | 242.13B | 31.75% |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 525.28T |
| SK hynix | 243.72T |
| LG Energy Solution | 82.95T |
| Samsung Biologics | 73.24T |
| Hanwha Aerospace | 52.63T |
| Hyundai Motor Company | 47.73T |
| HD Hyundai Heavy Industries | 44.34T |
| KB Financial Group | 42.75T |